Zydus Lifesciences (ZYDUSLIF) has shown resilience in the face of recent stock price corrections and rising competition in the U.S. generics market.

Prabhudas Lilladher has upgraded its recommendation for Harsha Engineers International (HARSHA) to “Accumulate” from “Hold,” setting a revised target price of Rs 561.

Prabhudas Lilladher has maintained an Accumulate rating on Shree Cement Ltd. (SRCM), with a revised target price of Rs 25,815.

Prabhudas Lilladher has issued an Accumulate rating on Aurobindo Pharma Ltd. (ARBP), setting a target price of Rs 1,475.

Prabhudas Lilladher maintains a Buy rating on Jupiter Life Line Hospitals (JLHL) with an upgraded target price of Rs 1,660.

Prabhudas Lilladher has upgraded Fine Organic Industries (FINEORG) to a Buy rating, setting a revised target price of Rs 5,852.